These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients. Almohsen F; Al-Mudallal SS Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):145-151. PubMed ID: 31438833 [TBL] [Abstract][Full Text] [Related]
9. Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species. Dou J; Li L; Guo M; Mei F; Zheng D; Xu H; Xue R; Bao X; Zhao F; Zhang Y Int J Nanomedicine; 2021; 16():1231-1244. PubMed ID: 33633448 [TBL] [Abstract][Full Text] [Related]
10. AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells. Fan D; Li Z; Zhang X; Yang Y; Yuan X; Zhang X; Yang M; Zhang Y; Xiong D J Hematol Oncol; 2015 Feb; 8():18. PubMed ID: 25879549 [TBL] [Abstract][Full Text] [Related]
11. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Guzman ML; Rossi RM; Karnischky L; Li X; Peterson DR; Howard DS; Jordan CT Blood; 2005 Jun; 105(11):4163-9. PubMed ID: 15687234 [TBL] [Abstract][Full Text] [Related]
13. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia. Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425 [TBL] [Abstract][Full Text] [Related]
14. MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients. Paprocka M; Bielawska-Pohl A; Rossowska J; Krawczenko A; Duś D; Kiełbiński M; Haus O; Podolak-Dawidziak M; Kuliczkowski K Eur J Haematol; 2017 Nov; 99(5):415-422. PubMed ID: 28805931 [TBL] [Abstract][Full Text] [Related]
15. Live kinase B1 maintains CD34 Wang H; Wang X; Xin N; Qi L; Liao A; Yang W; Liu Z; Zhao C Mol Cell Biochem; 2017 Oct; 434(1-2):25-32. PubMed ID: 28397012 [TBL] [Abstract][Full Text] [Related]
16. Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells. Lee WS; Ye Z; Cheung AMS; Goh YPS; Oh HLJ; Rajarethinam R; Yeo SP; Soh MK; Chan EHL; Tan LK; Tan SY; Chuah C; Chng WJ; Connolly JE; Wang CI Mol Cancer Ther; 2021 Sep; 20(9):1702-1712. PubMed ID: 34158344 [TBL] [Abstract][Full Text] [Related]
18. Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes. Yanagisawa B; Perkins B; Karantanos T; Levis M; Ghiaur G; Smith BD; Jones RJ Leuk Res; 2020 Dec; 99():106477. PubMed ID: 33220589 [TBL] [Abstract][Full Text] [Related]
19. Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML). Mitchell K; Steidl U Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31451539 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Jin L; Lee EM; Ramshaw HS; Busfield SJ; Peoppl AG; Wilkinson L; Guthridge MA; Thomas D; Barry EF; Boyd A; Gearing DP; Vairo G; Lopez AF; Dick JE; Lock RB Cell Stem Cell; 2009 Jul; 5(1):31-42. PubMed ID: 19570512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]